LESSONS FROM EUROPEAN VALUE-BASED HEALTH CARE SYSTEMS: HOW AN EMERGING FOCUS ON HEALTH CARE QUALITY WILL IMPACT THE PHARMACEUTICAL INDUSTRY IN THE UNITED STATES